Agulnik, Mark
Attia, Steven
Article History
First Online: 21 June 2018
Compliance with Ethical Standards
:
: The authors did not receive external funding for the preparation of this manuscript. Medical writing assistance was provided by Robert C. Ristuccia, PhD (Precept Medical Communications) and funded by Bayer HealthCare Pharmaceuticals.
: Dr. Attia’s institution has received research funding for the SARC024 and NU13S02 studies. Dr. Agulnik has received consulting fees and/or honoraria from Janssen, Eli Lilly, and Novartis and has received fees for participation in review activities from Eli Lilly.